CCL5 and pulmonary arterial hypertension: While CCL5 is claimed to promote the PAH progression via the BMPR2 signaling pathway, and CCL5 receptor CCR5 has been reported to be involved in the interaction between macrophages and smooth muscle cells (24, 25).